共 106 条
[1]
Ferlay J(2015)Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 Int J Cancer 136 E359-E386
[2]
Soerjomataram I(2006)Improving resectability of hepatic colorectal metastases: expert consensus statement Ann Surg Oncol 13 1271-1280
[3]
Dikshit R(1999)Factors influencing survival of patients undergoing hepatectomy for colorectal metastases Br J Surg 86 332-337
[4]
Abdalla EK(2009)Hepatic toxicities associated with the use of preoperative systemic therapy in patients with metastatic colorectal adenocarcinoma to the liver Oncologist 14 1095-1105
[5]
Adam R(2009)Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases Ann Surg 249 420-425
[6]
Bilchik AJ(2008)Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Lancet 371 1007-1016
[7]
Yamamoto J(2006)Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases J Clin Oncol 24 2065-2072
[8]
Shimada K(2008)Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy Ann Surg 247 118-124
[9]
Kosuge T(2004)Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer Ann Oncol 15 460-466
[10]
Cleary JM(2007)Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases Cancer 110 2761-2767